Pfizer is in talks with India and has pledged to make its COVID-19 vaccine available for deployment in the country, Reuters said citing the US drug maker. The company said it offered India a non-profit prize for its vaccine as part of the government’s vaccination program.
Last week, the Indian government said it would speed up emergency approvals for overseas-made COVID-19 vaccines, a move that would exempt companies from conducting “bridging” trials for their vaccines.
Meanwhile, Johnson & Johnson have said they are looking to conduct a local clinical trial in India for their single dose COVID-19 vaccine.
India is grappling with a massive increase in covidus cases which has severely strained its health system and caused oxygen and drug shortages.
India today recorded the world’s highest daily tally of 314,835 COVID-19 infections in a single day.
According to Reuters, the previous record one-day increase in cases was held by the United States, which had 297,430 new cases in one day in January, although the number has since declined sharply.
The total number of cases in India is now 15.93 million, while deaths have increased by 2,104 in the past 24 hours to a total of 184,657, according to the latest data from the Ministry of Health.
The Indian government will open its vaccination campaign from May 1 to cover people over 18.
This week, Prime Minister Narendra Modi urged state governments to use lockdowns as a last resort. He asked people to stay indoors and said the government was working to increase the supply of oxygen and vaccines.
Meanwhile, Pfizer has announced that it will deliver an additional 100 million doses of its COVID-19 vaccine to the 27 member states of the European Union (EU) in 2021. The announcement is the result of the European Commission decision ( CE) to exercise its option to purchase an additional 100 million doses under its expanded advance purchase agreement signed on February 17, 2021. This brings the total number of doses to be delivered to the EU to 600 million.